This page contains documents, including webinars, flyers, and publications, with Clinical Care guidance for health care professionals. See below for documents on the following subjects:
NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Video
Radiologists Describe Coronavirus Imaging Features
Therapeutics:
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Monoclonal Antibody Therapy
Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility (November 25, 2020)
Monoclonal Antibody Therapeutics: Bamlanivimab Therapy Plan
COVID-19 Therapeutics
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Remdesivir for the Treatment of Covid-19 — Final Report
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Lopinavir–ritonavir in patients admitted to hospital with COVID-19
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
The RECOVERY Platform
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Appropriate selection of convalescent plasma donors for COVID-19
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19
Remdesivir for the Treatment of Covid-19 — Preliminary Report
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Case Studies:
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes...
Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination
Covid-19–Associated Myopathy Caused by Type I Interferonopathy
Genomic evidence for reinfection with SARS-CoV-2: a case study
SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19
Surgical Cases and Considerations for COVID-19 Patients: Part 2
Surgical Cases and Considerations: Part 1
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
A 68-Year-Old Man with Covid-19 and Acute Kidney Injury
Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Clinical Characteristics of Covid-19 in New York City